Advertisement
    Earlier today
    Yesterday
    In the last 7 days
    Leading the Way in Rare Disease Advocacy Native News Online14:59 15-Jun-25
    Rare disease biotech announces milestone European Pharmaceutical Manufacturer15:12 13-Jun-25
    In the last month
    Abcuro Appoints Courtney Cupples as Chief Commercial Officer Business Wire (Press Release)12:00 9-Jun-25
    New blood test developed to rapidly diagnose rare genetic diseases Newcastle University (Press Release)14:21 6-Jun-25
    Vitamin B3 Slows Rapid Aging in Rare Disease Patients Science Blog (Weblog)15:10 5-Jun-25
    D-backs lace 'em up to raise awareness for rare disease Arizona Diamondbacks - Official Site17:04 4-Jun-25
    BIAL Announces Oral Presentation at GBA1 Meeting 2025 PR Newswire (Press Release)07:12 2-Jun-25
    Arcturus Therapeutics to Attend Upcoming Investor Conferences Business Wire (Press Release)21:07 29-May-25
    Seventy-eighth World Health Assembly – Daily update: 24 May 2025 World Health Organisation (Press Release)15:16 24-May-25
    First treatment for rare disease approved by UK medicines regulator UCL Hospitals Biomedical Research Centre (Press Release)13:25 22-May-25
    Access to Information Cited in National Organization for Rare Disorders Reports Journal of American Medical Associations16:50 21-May-25
    BioLineRx to Report First Quarter 2025 Results on May 27, 2025 PR Newswire (Press Release)12:01 20-May-25
    view more headlines
    18 Jun 00:15

    About our Rare Diseases news

    Latest news on rare diseases, providing comprehensive coverage of research breakthroughs, treatment developments, patient stories, and advocacy efforts for these often-overlooked conditions.

    Rare diseases, also known as orphan diseases, affect a small percentage of the population but collectively impact millions worldwide. With over 7,000 identified rare diseases, these conditions pose unique challenges for patients, healthcare providers, and researchers alike. According to the National Institutes of Health, a disease is considered rare if it affects fewer than 200,000 people in the United States.

    Recent advancements in genetic research and precision medicine have led to promising developments in the diagnosis and treatment of rare diseases. The European Joint Programme on Rare Diseases (EJP RD) continues to foster collaboration among researchers, clinicians, and patient organisations to accelerate progress. Additionally, the UK Rare Diseases Framework, launched in 2021, aims to improve the lives of those affected by rare conditions through enhanced diagnosis, treatment, and support.

    Patient advocacy groups play a crucial role in raising awareness and supporting those affected by rare diseases. Events like Rare Disease Day, observed annually on 29 February (or 28 February in non-leap years), bring global attention to these conditions. Personal stories of individuals living with rare diseases, such as cystic fibrosis, Huntington's disease, and Duchenne muscular dystrophy, highlight the daily challenges and triumphs experienced by patients and their families.

    The history of rare disease research dates back to the early 20th century, with significant milestones including the discovery of alkaptonuria by Sir Archibald Garrod in 1902. The Orphan Drug Act of 1983 in the United States and similar legislation in other countries have since incentivised pharmaceutical companies to develop treatments for rare conditions, leading to a surge in orphan drug approvals over the past few decades.

    Staying informed about rare diseases is crucial for patients, healthcare professionals, and policymakers alike. Our NewsNow feed provides comprehensive, up-to-date coverage from reliable sources, ensuring you have access to the latest breakthroughs, policy changes, and patient support initiatives in the field of rare diseases.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.